It focuses on the use of Deinococcus as a source of ingredients for use in animal nutrition
Boost your gains
Issued in China, N°1 in the world of breeding
Montpellier, on may 10, 2017 (18: 30 CEST) – DEINOVE (Alternext Paris : ALDEI), a biotech company that discovers, develops, and produces compounds with high added value from micro-organisms very rare, especially the kind Déinocoque, has announced that its first patent covering the use of Déinocoques for animal nutrition has been granted in China.
DEINOVE has been working since 2014 to develop applications for its biotechnology on the market of animal nutrition, in particular via two programs in partnership. The objective is to enhance the capacity of some strains from his collection bacterial to produce compounds with nutritional benefits and organoleptic.
This patent “Ingredients for animal feed compositions,” protects the progress made in this area. Filed in multiple jurisdictions, he got his first issue in China under the n°ZL 201280069505.2. Other deliverances of regional are expected.
Emmanuel PETIOT, ceo of DEINOVE, said : “This patent in detail the progress made by DEINOVE in the segment animal nutrition, an extremely dynamic market at the global level, driven by growth in population and changes in eating habits, including a request for more and stronger natural ingredients. China is the world’s largest producer of farmed animals [1], it is essential that we be able to term to market our innovations with all the protections required. However, this patent is intended to be issued in all other major territories.”
ABOUT DEINOVE
DEINOVE (Alternext Paris : ALDEI) is a biotechnology company that discovers, develops, and produces compounds of industrial interest from microorganisms, only a few for the areas of health, nutrition and cosmetics.
These modes of production, unreleased constitute a sustainable alternative and competitive.
To do this, DEINOVE relies on two key strengths :
A company’s microbial collection, unique in the world of 6 000 bacteria rare, and as yet unexploited, mainly of the genus Deinococcus ;
A platform for engineering genetic, metabolic, and fermentative owner that allows him to transform to how these micro-factories natural new industry standards.
Based in Montpellier, france, DEINOVE currently employs approximately 50 employees and has filed more than 160 patents to the international. The Company is listed on Alternext since April 2010.
Boost your gains